Evaluation of real-time quantitative PCR for identification and quantification of Chlamydia pneumoniae by comparison with immunohistochemistry

被引:50
作者
Mygind, T
Birkelund, S
Falk, E
Christiansen, G
机构
[1] Dept Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, DK-8200 Aarhus N, Denmark
关键词
Chlamydia pneumoniae; immunohistochemistry; lightcycler real-time PCR;
D O I
10.1016/S0167-7012(01)00282-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Chlamydia pneumoniae is a common cause of community-acquired pneumonia and it has been associated with atherosclerosis, C. pneumoniae has usually been diagnosed by serology using a microimmunofluorescence test. but more recently polymerase chain reaction (PCR) has been viewed as an advantageous alternative. We developed a quantitative real-time PCR for detection of C. pneumoniae. Primers were targeted for the pmp4 gene, and the PCR fragment was detected real-time with a fluorescence resonance energy transfer probe set using a LightCycler instrument. The PCR was used on DNA released from 50 mum sections of paraffin-embedded formalin-fixed lung tissue from experimentally infected mice. Thereby, the number of C. pneumoniae genomes was determined. To our knowledge this is the first rime quantification of C. pneumoniae DNA has: been attempted on paraffin-embedded formalin-fixed tissue. C. pneumoniae-specific immunohistochemistry (IHC) was done on 5 mum sections adjacent to the sections used in PCR, and the number of inclusions were counted in each section. Good correlation was found when comparing results from PCR and IHC, which is in contrast to many previous studies. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 251
页数:11
相关论文
共 30 条
  • [21] Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39
    Read, TD
    Brunham, RC
    Shen, C
    Gill, SR
    Heidelberg, JF
    White, O
    Hickey, EK
    Peterson, J
    Utterback, T
    Berry, K
    Bass, S
    Linher, K
    Weidman, J
    Khouri, H
    Craven, B
    Bowman, C
    Dodson, R
    Gwinn, M
    Nelson, W
    DeBoy, R
    Kolonay, J
    McClarty, G
    Salzberg, SL
    Eisen, J
    Fraser, CM
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (06) : 1397 - 1406
  • [22] *ROCH MOL BIOCH, 2000, OV LIGHC QUANT METH
  • [23] Chlamydia pneumoniae in atherosclerosis
    Saikku, P
    [J]. JOURNAL OF INTERNAL MEDICINE, 2000, 247 (03) : 391 - 396
  • [24] Sambrook J., 1989, MOL CLONING
  • [25] Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA
    Shirai, M
    Hirakawa, H
    Kimoto, M
    Tabuchi, M
    Kishi, F
    Ouchi, K
    Shiba, T
    Ishii, K
    Hattori, M
    Kuhara, S
    Nakazawa, T
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (12) : 2311 - 2314
  • [26] Chlamydia pneumoniae in atherosclerotic tissue
    Taylor-Robinson, D
    Thomas, BJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S437 - S440
  • [27] Wagner AD, 2000, ARTHRITIS RHEUM-US, V43, P1543, DOI 10.1002/1529-0131(200007)43:7<1543::AID-ANR19>3.3.CO
  • [28] 2-#
  • [29] Inhibition and facilitation of nucleic acid amplification
    Wilson, IG
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1997, 63 (10) : 3741 - 3751
  • [30] Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells
    Wolf, K
    Fischer, E
    Hackstadt, T
    [J]. INFECTION AND IMMUNITY, 2000, 68 (04) : 2379 - 2385